Camargo Pharmaceutical Services, a Cincinnati, Ohio-based provider of drug-development services, including 505(b)(2) drug development and global equivalents, has appointed Daniel S. Duffy as the firm’s new Chief Executive Officer. Kenneth V. Phelps, Founder and current President, will continue to be the visionary ambassador for the company.

Duffy brings over 20 years of experience in biopharma and strategic management consulting. Duffy was most recently the Vice President and General Manager at McKesson Specialty Health. While there, he developed a specialty pharmacy model with centers of excellence around oncology, neurology and complex care, patient assistance, and investigational product (clinical trials).

Source: Camargo Pharmaceutical Services